JP2016502091A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502091A5
JP2016502091A5 JP2015544592A JP2015544592A JP2016502091A5 JP 2016502091 A5 JP2016502091 A5 JP 2016502091A5 JP 2015544592 A JP2015544592 A JP 2015544592A JP 2015544592 A JP2015544592 A JP 2015544592A JP 2016502091 A5 JP2016502091 A5 JP 2016502091A5
Authority
JP
Japan
Prior art keywords
tnfα
labeled
sample
agents
autoantibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015544592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502091A (ja
Filing date
Publication date
Priority claimed from US13/802,117 external-priority patent/US20130266963A1/en
Application filed filed Critical
Priority claimed from PCT/IB2013/060458 external-priority patent/WO2014083520A2/en
Publication of JP2016502091A publication Critical patent/JP2016502091A/ja
Publication of JP2016502091A5 publication Critical patent/JP2016502091A5/ja
Pending legal-status Critical Current

Links

JP2015544592A 2012-11-30 2013-11-27 生物学的治療に対する中和自己抗体の検出のためのアッセイ Pending JP2016502091A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732251P 2012-11-30 2012-11-30
US61/732,251 2012-11-30
US13/802,117 US20130266963A1 (en) 2011-07-06 2013-03-13 Assay for detecting neutralizing autoantibodies to biologic therapy
US13/802,117 2013-03-13
PCT/IB2013/060458 WO2014083520A2 (en) 2012-11-30 2013-11-27 Assays for detecting neutralizing autoantibodies to biologic therapy

Publications (2)

Publication Number Publication Date
JP2016502091A JP2016502091A (ja) 2016-01-21
JP2016502091A5 true JP2016502091A5 (enExample) 2017-01-05

Family

ID=50828561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015544592A Pending JP2016502091A (ja) 2012-11-30 2013-11-27 生物学的治療に対する中和自己抗体の検出のためのアッセイ

Country Status (13)

Country Link
EP (1) EP2926136A2 (enExample)
JP (1) JP2016502091A (enExample)
KR (1) KR20150088890A (enExample)
CN (1) CN105074461A (enExample)
AU (1) AU2013350817A1 (enExample)
BR (1) BR112015012482A2 (enExample)
CA (1) CA2892766A1 (enExample)
HK (1) HK1215969A1 (enExample)
IL (1) IL238995A0 (enExample)
MX (1) MX2015006852A (enExample)
RU (1) RU2015125739A (enExample)
SG (2) SG10201703210XA (enExample)
WO (1) WO2014083520A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ621655A (en) 2009-10-26 2015-08-28 Nestec Sa Assays for the detection of anti-tnf drugs and autoantibodies
CN103299190B (zh) 2010-10-18 2017-02-15 雀巢产品技术援助有限公司 确定抗药物抗体同种型的方法
JP6181646B2 (ja) 2011-07-06 2017-08-16 ネステク ソシエテ アノニム Tnfアルファによる生物学的治療に対する中和自己抗体の検出のためのアッセイ
BR112017011545A2 (pt) 2014-12-05 2018-03-13 Nestec Sa ensaio de desvio de mobilidade homogênea indireto para a detecção de produtos biológicos nas amostras do paciente
US11085931B2 (en) 2015-01-09 2021-08-10 W. Health L.P. Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
CN109791142B (zh) * 2016-07-08 2022-11-29 W 健康公司 用于确定样品中治疗性单克隆抗体及其相应抗药物抗体的量的通用测定
US12480957B2 (en) 2017-03-31 2025-11-25 Ablynx N.V. Method of screening for anti-drug antibodies against immunoglobulin single variable domain-based drugs
EP4085254B1 (en) * 2020-01-02 2024-06-05 F. Hoffmann-La Roche AG Ada-response specification assay
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术(北京)有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
CN112730846B (zh) * 2020-12-18 2023-12-15 安渡生物医药(杭州)有限公司 一种用于小鼠血样检测免疫复合物的方法
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
CN117871856A (zh) * 2023-12-15 2024-04-12 首都医科大学附属北京地坛医院 可溶性因子在无症状神经梅毒检测中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ621655A (en) * 2009-10-26 2015-08-28 Nestec Sa Assays for the detection of anti-tnf drugs and autoantibodies
PT2564202E (pt) * 2010-04-29 2015-10-20 Theradiag Sa Métodos de deteção de anticorpos
CN103299190B (zh) * 2010-10-18 2017-02-15 雀巢产品技术援助有限公司 确定抗药物抗体同种型的方法
KR20140008397A (ko) * 2011-02-17 2014-01-21 네스텍 소시에테아노님 항-TNFα 약물에 대한 자가항체 검출을 위한 검정법
JP6181646B2 (ja) * 2011-07-06 2017-08-16 ネステク ソシエテ アノニム Tnfアルファによる生物学的治療に対する中和自己抗体の検出のためのアッセイ

Similar Documents

Publication Publication Date Title
JP2016502091A5 (enExample)
JP2014525036A5 (enExample)
JP2020536488A5 (enExample)
RU2015125739A (ru) Тесты детекции нейтрализующих аутоантител для биологической терапии
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
RU2015112024A (ru) Способы диагностики и лечения воспалительного заболевания кишечника
JP2013500941A5 (enExample)
JP2017508475A5 (enExample)
RU2012109004A (ru) Антитело против смет и его применение для определения и диагностики рака
JP2014512809A5 (enExample)
JP2021500916A5 (enExample)
JP2016536330A5 (enExample)
RU2013158256A (ru) АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα
RU2017107773A (ru) Антитела, специфичные к ммр9
RU2015145610A (ru) Применение биомаркеров для оценки лечения желудочно-кишечных воспалительных расстройств антагонистами бета7 интегрина
JP2016128441A5 (enExample)
RU2016116773A (ru) Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы
RU2014106658A (ru) Новое антитело к cxcr4 и его применение для выявления и диагностики рака
JP2018515071A5 (enExample)
JP2015533213A5 (enExample)
JP2014523920A5 (enExample)
FI3916392T3 (fi) Menetelmiä cd19-vasta-ainehoidon terapeuttisen hyödyn ennakoimiseksi potilailla
Schunn et al. Validation of a Dictyocaulus viviparus MSP-ELISA and cut-off adjustment in a one-year longitudinal field study in dairy cattle herds
JP2019513346A5 (enExample)
Millard et al. Detection of viral hemorrhagic septicemia virus-IVb antibodies in sera of muskellunge Esox masquinongy using competitive ELISA